Scinovex
review Open AccessTop 1% cited

Cancer nanomedicine: progress, challenges and opportunities

Nature reviews. Cancer · 2016 · Vol. 17(1) · pp. 20–37
Jinjun ShiPhilip W. KantoffRichard WoosterOmid C. Farokhzad
Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsGraphene and Nanomaterials ApplicationsNanomedicineCommercializationCancerCancer therapyNanotechnologyCancer treatmentSAFERMedicineEngineering ethicsEngineering

MeSH terms

HumansNeoplasmsNanotechnologyNanomedicine

Funding

  • U.S. Department of Defense
  • Prostate Cancer Foundation
  • Movember Foundation
  • National Research Foundation
  • National Research Foundation of Korea
  • National Institutes of Health
  • DOD Prostate Cancer Research Program
Citations
5,494
FWCI
248.31
field-weighted impact
References
249
Percentile
100%
vs. same field & year
Citations per year
References
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Journal of Controlled Release · 2015 · 1,095 citations
Knocking down barriers: advances in siRNA delivery
Nature Reviews Drug Discovery · 2009 · 3,091 citations
Tumor Angiogenesis: Therapeutic Implications
New England Journal of Medicine · 1971 · 10,087 citations
PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer Drugs
Journal of the American Chemical Society · 2008 · 3,582 citations
Cancer nanotechnology: opportunities and challenges
Nature reviews. Cancer · 2005 · 4,505 citations
Doxil® — The first FDA-approved nano-drug: Lessons learned
Journal of Controlled Release · 2012 · 4,472 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.